Skip to content

Effects of Connective Tissue Massage in Women With Overactive Bladder

Assistant Professor, Physioterapist, PhD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03695692
Enrollment
40
Registered
2018-10-04
Start date
2018-05-02
Completion date
2019-10-31
Last updated
2018-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Brief summary

The aim of this study was to compare the effects of pelvic floor muscle trainig with connective tissue massage and only pelvic floor muscle training in women with overactive bladder

Interventions

BEHAVIORALpelvic floor exercise and connective tissue massage

Pelvic floor exercises with connective tissue massage will be performed.The massage program is carried out for 18 sessions, 3 days/week in 6 weeks. The exercise program is performed every day for 6 weeks

The exercise program is performed every day for 6 weeks

Sponsors

Seyda TOPRAK CELENAY
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 65 years of age, * having overactive bladder * being volunteer

Exclusion criteria

* being in the period of pregnancy or breastfeeding, * having an accompanying neurological disease, presence of a mental issue that would prevent cooperation in examinations and/or implementations, history of acute infectionor presence of a malignce

Design outcomes

Primary

MeasureTime frameDescription
overactive bladder symptoms measured by Overactive Bladder Questionnaire_V8Change from baseline bladder symptoms at 6 weeksOveractive Bladder Questionnaire\_V8 assessing severity of overactive bladder symptoms will be used. This scale includes items on urgency, incontinence, nocturia and voiding frequency, as defined by the International Continence Society, referring to the previous four weeks. The final score is the sum of the partial scores obtained for each of the eight questions, ranging from 0 to 40. Patients with a final score of eight or more are considered as having Overactive Bladder symptoms.

Secondary

MeasureTime frameDescription
urgency complaint assessed with The patient's Perception of Intensity of Urgency ScaleChange from baseline urgency complaints at 6 weeksThe patient's Perception of Intensity of Urgency Scale assessing urgency complaints will be used. This scale is scored on 0 and 4 points (the best score is '0' and the worst score is '4') based on urgency complaints. Higher scores indicate more severe urgency complaints.
quality of life assessed with King's Health Questionnaire (KHQ)Change from baseline quality of life at 6 weeksKing's Health Questionnaire assessing quality of life related to urinary problems will be used. This questionnaire consists of two parts and 32 items. The first part (21 items) contains two single-item questions that address General Health Perception and Incontinence Impact and the following seven multi-item domains: Role, Physical, and Social Limitations, Limitations in Personal Relationship, Emotional Problems, Sleep and Energy Disturbances associated with UI, and Severity Measures for UI. The second part has an 11-item Symptom Severity Scale (SSS) that assesses the presence and severity of urinary symptoms. While the entire SSS is scored from 0 (best) to 30 (worst), the minimum possible score is 0 (best health) and the maximum possible score is 100 (worst health) for all other KHQ domains.
pelvic floor muscle strength measured with perineometerChange from baseline pelvic floor muscle strength at 6 weekschange in pelvic floor muscle strength as measued with perineometer
diurnal urinary frequency, nocturia, maximum urinary volume, the number of urinary leakage and pad changes measured with voiding dairyChange from baseline diurnal urinary frequency, nocturia, maximum urinary volume, the number of urinary leakage and pad changes at 6 weeksPatients will be also instructed to keep voiding diary for three days. In this diary, diurnal urinary frequency, nocturia, maximum urinary volume, the number of urinary leakage and pad changes will be recorded.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSeyda TOPRAK CELENAY
sydtoprak@hotmail.com+90-534-041-3986
Backup ContactYasemin KARAASLAN
ptyasemindeveci@gmail.com+90 535 845 9625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026